7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2022-03-31 2020-03-31 2019-03-31 2018-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-03-31 2009-09-30 2009-06-30 2009-03-31 
      
    		                              
      assets
    		                              
      investments:
    		                              
      fixed maturity available-for-sale securities, at fair value
    		          98,050,000,000                    
      trading securities
    		1,853,000,000 1,909,000,000 1,984,000,000 2,025,000,000 2,206,000,000 2,201,000,000 2,227,000,000 2,359,000,000 4,385,000,000 4,019,000,000 3,314,000,000 1,553,000,000 1,914,000,000 1,949,000,000 2,077,000,000 2,134,000,000 2,339,000,000 2,316,000,000 2,354,000,000 2,391,000,000 2,528,000,000 2,554,000,000 2,650,000,000 2,649,000,000 2,650,000,000 2,675,000,000 2,598 2,548,000,000 2,317,000,000 2,246,000,000 
      equity securities
    		542,000,000 341,000,000 345,000,000 294,000,000 293,000,000 295,000,000 319,000,000 306,000,000 346,000,000 83,000,000 153,000,000 112,000,000 242,000,000 227,000,000 210,000,000 234,000,000 256,000,000 207,000,000 185,000,000 209,000,000 148,000,000 157,000,000         
      mortgage loans on real estate, net of allowance for credit losses
    		                              
      policy loans
    		2,584,000,000 2,552,000,000 2,529,000,000 2,476,000,000 2,510,000,000 2,513,000,000 2,476,000,000 2,476,000,000 2,339,000,000 2,571,000,000 2,498,000,000 2,389,000,000 2,647,000,000 2,654,000,000 2,664,000,000 2,677,000,000 2,683,000,000 2,687,000,000 2,679,000,000 2,700,000,000 2,727,000,000 2,766,000,000 2,780,000,000 2,829,000,000 2,842,000,000 2,884,000,000 2,837 2,893,000,000 2,897,000,000 2,908,000,000 
      derivative investments
    		10,427,000,000 8,349,000,000 7,849,000,000 9,677,000,000 9,522,000,000 8,608,000,000 8,394,000,000 6,474,000,000 4,840,000,000 4,417,000,000 981,000,000 827,000,000 2,020,000,000 1,340,000,000 2,095,000,000 1,439,000,000 1,142,000,000 1,044,000,000 1,114,000,000 1,683,000,000 2,268,000,000 2,652,000,000 3,072,000,000 3,399,000,000 2,244,000,000 3,151,000,000 946 1,282,000,000 1,234,000,000 2,226,000,000 
      other investments
    		7,786,000,000 6,611,000,000 6,653,000,000 6,588,000,000 5,743,000,000 5,652,000,000 5,256,000,000 5,015,000,000 4,127,000,000 4,765,000,000 2,752,000,000 2,049,000,000 1,820,000,000 1,624,000,000 1,885,000,000 1,469,000,000 1,301,000,000 1,237,000,000 1,219,000,000 1,158,000,000 1,073,000,000 1,098,000,000 1,123,000,000 1,041,000,000 1,043,000,000 1,069,000,000 1,029 1,080,000,000 1,187,000,000 1,476,000,000 
      total investments
    		136,102,000,000 131,144,000,000 129,215,000,000 129,254,000,000 131,812,000,000 126,595,000,000 125,702,000,000 124,331,000,000 144,624,000,000 135,252,000,000 121,745,000,000 110,047,000,000 103,199,000,000 102,009,000,000 106,015,000,000 101,385,000,000 100,958,000,000 98,207,000,000 95,568,000,000 96,167,000,000 99,285,000,000 99,065,000,000      76,183,000,000 70,548,000,000 66,155,000,000 
      cash and invested cash
    		10,668,000,000 7,143,000,000 4,284,000,000 5,801,000,000 6,013,000,000 5,475,000,000 4,122,000,000 3,365,000,000 1,960,000,000 6,202,000,000 1,593,000,000 2,257,000,000 3,772,000,000 2,327,000,000 3,487,000,000 1,821,000,000 1,509,000,000 1,849,000,000 2,650,000,000 2,574,000,000 3,107,000,000 4,230,000,000 4,373,000,000 5,257,000,000 3,516,000,000 4,510,000,000 2,216 3,161,000,000 2,539,000,000 5,613,000,000 
      deferred acquisition costs, value of business acquired and deferred sales inducements
    		12,681,000,000 12,604,000,000 12,563,000,000 12,537,000,000 12,475,000,000 12,435,000,000 12,405,000,000 12,397,000,000                       
      reinsurance recoverables, net of allowance for credit losses
    		28,665,000,000 28,440,000,000 28,580,000,000 28,750,000,000 29,233,000,000 29,126,000,000 29,461,000,000 29,843,000,000 20,044,000,000 16,923,000,000                     
      deposit assets, net of allowance for credit losses
    		33,066,000,000 31,754,000,000 31,048,000,000 30,776,000,000 30,501,000,000 29,888,000,000 28,904,000,000 28,789,000,000                       
      market risk benefit assets
    		4,694,000,000 4,577,000,000 4,157,000,000 4,860,000,000 4,565,000,000 4,754,000,000 4,878,000,000 3,894,000,000                       
      accrued investment income
    		1,172,000,000 1,136,000,000 1,134,000,000 1,108,000,000 1,160,000,000 1,135,000,000 1,127,000,000 1,082,000,000 1,247,000,000 1,185,000,000 1,184,000,000 1,137,000,000 1,116,000,000 1,064,000,000 1,129,000,000 1,129,000,000 1,081,000,000 1,116,000,000 1,111,000,000 1,052,000,000 1,078,000,000 1,015,000,000 1,067,000,000 1,021,000,000 1,026,000,000 981,000,000 989 943,000,000 881,000,000 881,000,000 
      goodwill
    		1,144,000,000 1,144,000,000 1,144,000,000 1,144,000,000 1,144,000,000 1,144,000,000 1,144,000,000 1,144,000,000 1,778,000,000 1,778,000,000 1,778,000,000 1,368,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 2,273,000,000 3,019 3,096,000,000 3,344,000,000 3,344,000,000 
      other assets
    		7,223,000,000 8,181,000,000 8,267,000,000 8,163,000,000 8,454,000,000 8,782,000,000 9,413,000,000 9,311,000,000 17,406,000,000 16,246,000,000 16,373,000,000 6,313,000,000 3,450,000,000 3,647,000,000 2,901,000,000 3,414,000,000 3,760,000,000 3,822,000,000 2,709,000,000 2,655,000,000 2,569,000,000 2,580,000,000 2,502,000,000 2,475,000,000 2,486,000,000 2,536,000,000 3,293 10,827,000,000 9,982,000,000 3,396,000,000 
      separate account assets
    		179,860,000,000 172,942,000,000 162,506,000,000 168,438,000,000 171,483,000,000 165,199,000,000 166,225,000,000 158,257,000,000 168,879,000,000 130,617,000,000 143,369,000,000 142,761,000,000 120,275,000,000 128,079,000,000 127,828,000,000 122,937,000,000 124,159,000,000 118,968,000,000 109,376,000,000 102,783,000,000 101,366,000,000 95,373,000,000 93,326,000,000 88,839,000,000 91,088,000,000 83,477,000,000 88,236 70,111,000,000 61,091,000,000 57,487,000,000 
      total assets
    		415,275,000,000 399,065,000,000 382,898,000,000 390,831,000,000 396,840,000,000 384,533,000,000 383,381,000,000 372,413,000,000 365,929,000,000 318,649,000,000 314,299,000,000 279,237,000,000 249,532,000,000 255,214,000,000 258,485,000,000 248,446,000,000 249,125,000,000 241,949,000,000 229,924,000,000 223,321,000,000 224,341,000,000 218,869,000,000      181,490,000,000 167,045,000,000 157,427,000,000 
      liabilities and stockholders’ equity
    		                              
      liabilities
    		                              
      policyholder account balances
    		133,223,000,000 129,209,000,000 125,262,000,000 126,197,000,000 125,968,000,000 124,113,000,000 122,300,000,000 120,737,000,000                       
      future contract benefits
    		41,852,000,000 41,053,000,000 40,665,000,000 39,807,000,000 41,169,000,000 38,560,000,000 38,848,000,000 39,864,000,000 39,773,000,000 37,100,000,000 34,009,000,000 22,923,000,000 20,523,000,000 20,166,000,000 20,468,000,000 19,553,000,000 19,460,000,000 18,997,000,000 18,138,000,000 18,214,000,000 19,149,000,000 19,780,000,000 19,232,000,000 19,930,000,000 18,784,000,000 19,813,000,000 17,313 15,970,000,000 16,128,000,000 18,836,000,000 
      funds withheld reinsurance liabilities
    		17,559,000,000 16,700,000,000 16,838,000,000 16,907,000,000 17,595,000,000 17,044,000,000 17,486,000,000 17,641,000,000 2,164,000,000 1,843,000,000 1,762,000,000 1,726,000,000 676,000,000 718,000,000 717,000,000 806,000,000 842,000,000 843,000,000 898,000,000 926,000,000 926,000,000 940,000,000 987,000,000 999,000,000 1,043,000,000 1,045,000,000 1,135 1,220,000,000 1,222,000,000 1,215,000,000 
      market risk benefit liabilities
    		1,190,000,000 1,205,000,000 1,306,000,000 1,046,000,000 1,272,000,000 1,275,000,000 1,266,000,000 1,716,000,000                       
      deferred front-end loads
    		7,349,000,000 7,119,000,000 6,910,000,000 6,730,000,000 6,517,000,000 6,306,000,000 6,099,000,000 5,901,000,000                       
      payables for collateral on investments
    		11,153,000,000 8,466,000,000 8,282,000,000 10,020,000,000 10,570,000,000 11,114,000,000 10,117,000,000 8,105,000,000 8,927,000,000 8,434,000,000 5,362,000,000 4,265,000,000 5,297,000,000 4,587,000,000 5,046,000,000 3,853,000,000 3,571,000,000 3,519,000,000 3,553,000,000 4,252,000,000 4,107,000,000 4,181,000,000 4,566,000,000 5,070,000,000 2,875,000,000 3,733,000,000 1,554 2,240,000,000   
      short-term debt
    		   300,000,000 300,000,000 450,000,000 503,000,000 250,000,000   300,000,000 250,000,000   250,000,000 250,000,000 250,000,000  503,000,000 506,000,000 706,000,000 200,000,000 200,000,000 300,000,000 300,000,000 300,000,000 351 400,000,000 455,000,000 1,436,000,000 
      long-term debt
    		5,772,000,000 5,767,000,000 5,868,000,000 5,856,000,000 5,897,000,000 5,716,000,000 5,726,000,000 5,699,000,000 6,561,000,000 6,748,000,000 5,572,000,000 5,648,000,000 5,604,000,000 5,529,000,000 5,627,000,000 5,186,000,000 5,170,000,000 5,380,000,000 5,365,000,000 5,050,000,000 4,889,000,000 5,439,000,000 5,494,000,000 5,719,000,000 5,606,000,000 5,391,000,000 5,370 4,789,000,000 4,775,000,000 4,345,000,000 
      other liabilities
    		6,865,000,000 7,056,000,000 7,068,000,000 7,261,000,000 7,056,000,000 6,807,000,000 7,265,000,000 7,350,000,000 12,012,000,000 17,824,000,000 13,372,000,000 4,934,000,000 6,071,000,000 4,936,000,000 6,340,000,000 5,168,000,000 5,114,000,000 4,866,000,000 4,145,000,000 3,929,000,000 4,993,000,000 5,139,000,000 5,036,000,000 4,950,000,000 4,352,000,000 4,762,000,000 3,472 10,598,000,000 9,631,000,000 2,326,000,000 
      separate account liabilities
    		179,860,000,000 172,942,000,000 162,506,000,000 168,438,000,000 171,483,000,000 165,199,000,000 166,225,000,000 158,257,000,000 168,879,000,000 130,617,000,000 143,369,000,000 142,761,000,000 120,275,000,000 128,079,000,000 127,828,000,000 122,937,000,000 124,159,000,000 118,968,000,000 109,376,000,000 102,783,000,000 101,366,000,000 95,373,000,000 93,326,000,000 88,839,000,000 91,088,000,000 83,477,000,000 88,236 70,111,000,000 61,091,000,000 57,487,000,000 
      total liabilities
    		404,823,000,000 389,517,000,000 374,705,000,000 382,562,000,000 387,827,000,000 376,584,000,000 375,835,000,000 365,520,000,000 351,217,000,000 302,074,000,000 297,882,000,000 263,252,000,000 235,131,000,000 240,515,000,000 242,262,000,000 232,994,000,000 233,674,000,000 227,463,000,000 216,535,000,000 210,004,000,000 209,479,000,000 203,896,000,000      169,834,000,000 157,970,000,000 150,104,000,000 
      contingencies and commitments
    		                              
      stockholders’ equity
    		                              
      preferred stock – 10,000,000 shares authorized:
    		                              
      series c preferred stock – 20,000 shares authorized, issued and outstanding
    		                              
      as of september 30, 2025, and december 31, 2024
    		493,000,000                              
      series d preferred stock – 20,000 shares authorized, issued and outstanding
    		                              
      common stock – 800,000,000 shares authorized; 189,920,627 and 170,380,646 shares
    		                              
      issued and outstanding as of september 30, 2025, and december 31, 2024, respectively
    		5,574,000,000                              
      retained earnings
    		7,731,000,000 7,409,000,000 6,810,000,000 7,645,000,000 6,049,000,000 6,691,000,000 5,887,000,000 4,778,000,000 8,876,000,000 8,500,000,000 8,679,000,000 8,052,000,000 6,358,000,000 6,286,000,000 6,077,000,000 5,834,000,000 5,513,000,000 5,228,000,000 4,753,000,000 4,487,000,000 4,238,000,000 4,044,000,000 3,873,000,000 3,493,000,000 3,191,000,000 4,126,000,000 4,243 3,234,000,000 3,101,000,000 3,265,000,000 
      accumulated other comprehensive income
    		-3,839,000,000 -4,392,000,000 -4,306,000,000 -5,036,000,000 -2,682,000,000 -4,369,000,000 -3,951,000,000 -3,476,000,000 1,250,000,000 3,004,000,000 2,453,000,000 2,233,000,000 1,663,000,000 1,944,000,000 3,653,000,000 2,922,000,000 3,199,000,000 2,453,000,000 1,750,000,000 1,893,000,000 3,581,000,000 3,808,000,000 4,150,000,000 3,379,000,000 2,622,000,000 2,448,000,000 783    
      total stockholders’ equity
    		10,452,000,000 9,548,000,000 8,193,000,000 8,269,000,000 9,013,000,000 7,949,000,000 7,546,000,000 6,893,000,000 14,712,000,000 16,575,000,000 16,417,000,000 15,985,000,000 14,401,000,000 14,699,000,000 16,223,000,000 15,452,000,000 15,451,000,000              
      total liabilities and stockholders’ equity
    		415,275,000,000 399,065,000,000 382,898,000,000 390,831,000,000 396,840,000,000 384,533,000,000 383,381,000,000 372,413,000,000 365,929,000,000 318,649,000,000 314,299,000,000 279,237,000,000 249,532,000,000 255,214,000,000 258,485,000,000 248,446,000,000 249,125,000,000              
      as of june 30, 2025, and december 31, 2024
    		 493,000,000                             
      common stock – 800,000,000 shares authorized; 189,570,904 and 170,380,646 shares
    		                              
      issued and outstanding as of june 30, 2025, and december 31, 2024, respectively
    		 5,545,000,000                             
      as of march 31, 2025, and december 31, 2024
    		  493,000,000                            
      common stock – 800,000,000 shares authorized; 170,695,166 and 170,380,646 shares
    		                              
      issued and outstanding as of march 31, 2025, and december 31, 2024, respectively
    		  4,703,000,000                            
      as of december 31, 2024, and december 31, 2023
    		   493,000,000                           
      common stock – 800,000,000 shares authorized; 170,380,646 and 169,666,137 shares
    		                              
      issued and outstanding as of december 31, 2024, and december 31, 2023, respectively
    		   4,674,000,000                           
      as of september 30, 2024, and december 31, 2023
    		    493,000,000                          
      common stock – 800,000,000 shares authorized; 170,341,467 and 169,666,137 shares
    		                              
      issued and outstanding as of september 30, 2024, and december 31, 2023, respectively
    		    4,660,000,000                          
      as of june 30, 2024, and december 31, 2023
    		     493,000,000                         
      common stock – 800,000,000 shares authorized; 170,188,487 and 169,666,137 shares
    		                              
      issued and outstanding as of june 30, 2024, and december 31, 2023, respectively
    		     4,641,000,000                         
      as of march 31, 2024, and december 31, 2023
    		      493,000,000                        
      common stock – 800,000,000 shares authorized; 170,016,887 and 169,666,137 shares
    		                              
      issued and outstanding as of march 31, 2024, and december 31, 2023, respectively
    		      4,624,000,000                        
      series c preferred stock – 20,000 shares authorized, issued and outstanding as of december 31, 2023
    		       493,000,000                       
      series d preferred stock – 20,000 shares authorized, issued and outstanding as of december 31, 2023
    		       493,000,000                       
      common stock – 800,000,000 shares authorized; 169,666,137 and 169,220,511 shares
    		                              
      issued and outstanding as of december 31, 2023, and december 31, 2022, respectively
    		       4,605,000,000                       
      deferred acquisition costs and value of business acquired
    		        8,810,000,000 9,212,000,000 9,441,000,000 9,289,000,000 8,866,000,000 9,150,000,000 8,156,000,000 8,372,000,000 8,149,000,000 8,454,000,000 8,500,000,000 8,214,000,000 6,936,000,000 6,667,000,000 5,813,000,000 6,505,000,000 6,880,000,000 8,191,000,000 9,272 9,182,000,000 10,456,000,000 11,922,000,000 
      premiums and fees receivable
    		        671,000,000 562,000,000 607,000,000 480,000,000 383,000,000 415,000,000 452,000,000 448,000,000 465,000,000 504,000,000 427,000,000 430,000,000 440,000,000 380,000,000 366,000,000 388,000,000 437,000,000 408,000,000 401 323,000,000 429,000,000 489,000,000 
      funds withheld reinsurance assets
    		        510,000,000 535,000,000 549,000,000 576,000,000 639,000,000 642,000,000 646,000,000 761,000,000 764,000,000 772,000,000 782,000,000 788,000,000 798,000,000 837,000,000 846,000,000 863,000,000 866,000,000 874,000,000     
      other contract holder funds
    		        112,901,000,000 99,508,000,000 93,959,000,000 80,710,000,000 76,451,000,000 76,243,000,000 75,663,000,000 74,893,000,000 74,735,000,000 74,507,000,000 74,106,000,000 73,830,000,000 72,760,000,000 72,218,000,000 70,706,000,000 70,422,000,000 70,027,000,000 69,466,000,000 67,125 63,956,000,000 62,427,000,000 61,525,000,000 
      reinsurance-related embedded derivatives
    		                              
      preferred stock – 10,000,000 shares authorized
    		                              
      common stock – 800,000,000 shares authorized; 171,890,974 and 177,193,515 shares
    		                              
      issued and outstanding as of march 31, 2022, and december 31, 2021, respectively
    		        4,586,000,000                      
      reinsurance related embedded derivatives
    		         137,000,000 177,000,000 34,000,000 116,000,000 120,000,000 165,000,000 141,000,000 155,000,000 135,000,000 121,000,000 131,000,000 199,000,000 215,000,000 215,000,000 185,000,000 158,000,000 168,000,000 91 39,000,000   
      common stock – 800,000,000 shares authorized; 193,208,244 and 196,668,532 shares
    		                              
      issued and outstanding as of march 31, 2020, and december 31, 2019, respectively
    		         5,071,000,000                     
      mortgage loans on real estate
    		          13,997,000,000 11,047,000,000 8,431,000,000 8,171,000,000 7,654,000,000 7,466,000,000 7,096,000,000 7,089,000,000 7,127,000,000 7,033,000,000 7,057,000,000 7,029,000,000 6,690,000,000 6,804,000,000 6,938,000,000 6,942,000,000 6,749 7,277,000,000 7,468,000,000 7,616,000,000 
      reinsurance recoverables
    		          17,660,000,000 5,009,000,000 5,559,000,000 5,608,000,000 5,598,000,000 5,906,000,000 6,007,000,000 5,984,000,000 6,528,000,000 6,385,000,000 6,489,000,000 6,449,000,000 6,424,000,000 6,601,000,000 6,534,000,000 6,526,000,000 6,580 7,664,000,000 7,729,000,000 8,033,000,000 
      common stock – 800,000,000 shares authorized; 202,987,229 and 205,862,760 shares
    		                              
      issued and outstanding as of march 31, 2019, and december 31, 2018, respectively
    		          5,285,000,000                    
      available-for-sale securities, at fair value:
    		                              
      fixed maturity securities
    		           92,059,000,000 85,506,000,000 85,422,000,000 88,813,000,000 85,348,000,000 85,511,000,000 82,988,000,000 80,135,000,000 80,235,000,000 82,711,000,000 82,036,000,000         
      real estate
    		           11,000,000 21,000,000 24,000,000 19,000,000 20,000,000 32,000,000 42,000,000 56,000,000 60,000,000 65,000,000 65,000,000 112,000,000 116,000,000 113,000,000 137,000,000 189 154,000,000 159,000,000 129,000,000 
      deferred gain on business sold through reinsurance
    		           1,000,000 116,000,000 134,000,000 153,000,000 190,000,000 208,000,000 226,000,000 263,000,000 282,000,000 301,000,000 319,000,000 338,000,000 356,000,000 375,000,000 394,000,000 450 511,000,000 529,000,000 548,000,000 
      common stock – 800,000,000 shares authorized; 218,695,476 and 218,090,114 shares
    		                              
      issued and outstanding as of march 31, 2018, and december 31, 2017, respectively
    		           5,700,000,000                   
      variable interest entities’ fixed maturity securities
    		            598,000,000 598,000,000 598,000,000 598,000,000 598,000,000              
      variable interest entities’ liabilities
    		            2,000,000 3,000,000 5,000,000 17,000,000 10,000,000              
      common stock – 800,000,000 shares authorized; 247,464,931 and 256,551,440 shares
    		                              
      issued and outstanding as of september 30, 2015, and december 31, 2014, respectively
    		            6,380,000,000                  
      common stock – 800,000,000 shares authorized; 250,918,893 and 256,551,440 shares
    		                              
      issued and outstanding as of june 30, 2015, and december 31, 2014, respectively
    		             6,469,000,000                 
      common stock – 800,000,000 shares authorized; 252,928,502 and 256,551,440 shares
    		                              
      issued and outstanding as of march 31, 2015, and december 31, 2014, respectively
    		              6,493,000,000                
      common stock – 800,000,000 shares authorized; 259,786,446 and 262,896,701 shares
    		                              
      issued and outstanding as of september 30, 2014, and december 31, 2013, respectively
    		               6,696,000,000               
      common stock – 800,000,000 shares authorized; 260,831,708 and 262,896,701 shares
    		                              
      issued and outstanding as of june 30, 2014, and december 31, 2013, respectively
    		                6,739,000,000              
      variable interest entities' fixed maturity securities
    		                 597,000,000 699,000,000 698,000,000 708,000,000 708,000,000         
      liabilities and stockholders' equity
    		                              
      variable interest entities' liabilities
    		                 22,000,000 67,000,000 101,000,000 83,000,000 92,000,000 121,000,000 158,000,000 149,000,000 193,000,000 130    
      stockholders' equity
    		                              
      common stock – 800,000,000 shares authorized; 263,682,162 and 262,896,701 shares
    		                              
      issued and outstanding as of march 31, 2014, and december 31, 2013, respectively
    		                 6,805,000,000             
      total stockholders' equity
    		                 14,486,000,000 13,389,000,000 13,317,000,000 14,862,000,000 14,973,000,000      11,656,000,000 9,075,000,000 7,323,000,000 
      total liabilities and stockholders' equity
    		                 241,949,000,000 229,924,000,000 223,321,000,000 224,341,000,000 218,869,000,000      181,490,000,000 167,045,000,000 157,427,000,000 
      preferred stock – 10,000,000 shares authorized; series a – 9,532 shares issued and
    		                              
      outstanding as of december 31, 2012
    		                              
      common stock – 800,000,000 shares authorized; 262,342,363 and 271,402,586 shares
    		                              
      issued and outstanding as of september 30, 2013, and december 31, 2012, respectively
    		                  6,886,000,000            
      preferred stock – 10,000,000 shares authorized; series a – 4,164 and 9,532
    		                              
      shares issued and outstanding as of june 30, 2013, and december 31, 2012, respectively
    		                              
      common stock – 800,000,000 shares authorized; 264,316,340 and 271,402,586 shares
    		                              
      issued and outstanding as of june 30, 2013, and december 31, 2012, respectively
    		                   6,937,000,000           
      preferred stock – 10,000,000 shares authorized; series a – 9,532 shares issued and outstanding as of march 31, 2013, and december 31, 2012
    		                              
      common stock – 800,000,000 shares authorized; 268,457,558 and 271,402,586 shares issued and outstanding as of march 31, 2013, and december 31, 2012, respectively
    		                    7,043,000,000          
      preferred stock - 10,000,000 shares authorized; series a - 9,532 and 10,072 shares issued and outstanding as of december 31, 2012, and december 31, 2011, respectively
    		                              
      common stock - 800,000,000 shares authorized; 271,402,586 and 291,319,222 shares issued and outstanding as of december 31, 2012, and december 31, 2011, respectively
    		                     7,121,000,000         
      preferred stock - 10,000,000 shares authorized; series a - 9,532 and 10,072 sharesissued and outstanding as of september 30, 2012, and december 31, 2011, respectively
    		                              
      common stock - 800,000,000 shares authorized; 275,073,618 and 291,319,222 shares issued and outstanding as of september 30, 2012, and december 31, 2011, respectively
    		                      7,214,000,000        
      preferred stock - 10,000,000 shares authorized; series a - 9,632 and 10,072 shares issued and outstanding as of june 30, 2012, and december 31, 2011, respectively
    		                              
      common stock - 800,000,000 shares authorized; 279,168,971 and 291,319,222 shares issued and outstanding as of june 30, 2012, and december 31, 2011, respectively
    		                       7,310,000,000       
      preferred stock - 10,000,000 shares authorized; series a - 9,632 and 10,072 shares
    		                              
      common stock - 800,000,000 shares authorized; 285,412,303 and 291,319,222 shares
    		                              
      preferred stock - 10,000,000 shares authorized; series a - 10,072 and 10,914 shares issued and outstanding as of december 31, 2011, and december 31, 2010, respectively
    		                              
      common stock - 800,000,000 shares authorized; 291,319,222 and 315,718,554 shares issued and outstanding as of december 31, 2011, and december 31, 2010, respectively
    		                         7,590,000,000     
      preferred stock - 10,000,000 shares authorized:
    		                              
      series a preferred stock - 10,914 and 10,914 shares issued and outstanding
    		                              
      common stock - 800,000,000 shares authorized; 313,456,824 and 315,718,554 shares
    		                              
      fixed maturity
    		                           60,666,000,000 55,050,000,000 49,349,000,000 
      equity
    		                           283,000,000 236,000,000 205,000,000 
      series a preferred stock – 10,000,000 shares authorized; 11,547 and 11,562 shares
    		                              
      issued and outstanding as of september 30, 2009, and december 31, 2008, respectively
    		                           7,842,000,000   
      series b preferred stock – 950,000 shares authorized and outstanding
    		                              
      as of september 30, 2009
    		                           800,000,000   
      common stock – 800,000,000 shares authorized; 302,073,869 and 255,869,859 shares
    		                              
      accumulated other comprehensive loss
    		                           -220,000,000 -1,707,000,000 -2,975,000,000 
      reinsurance related derivative assets
    		                            46,000,000 107,000,000 
      payables for collateral under securities loaned and derivatives
    		                            1,712,000,000 2,386,000,000 
      series a preferred stock - 10,000,000 shares authorized
    		                              
      common stock - 800,000,000 shares authorized; 302,093,017 and 255,869,859 shares
    		                              
      issued and outstanding as of june 30, 2009, and december 31, 2008, respectively
    		                            7,681,000,000  
      common stock - 800,000,000 shares authorized; 256,046,103 and 255,869,859 shares
    		                              
      issued and outstanding as of march 31, 2009, and december 31, 2008, respectively
    		                             7,033,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.